| Previous Close | 65.46 |
| Open | 65.58 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 64.85 - 65.89 |
| 52 Week Range | 34.58 - 65.91 |
| Volume | 201,006 |
| Avg. Volume | 234,830 |
| Market Cap | 2.21B |
| Beta | 1.46 |
| PE Ratio (TTM) | 48.44 |
| EPS (TTM) | 1.35 |
| Earnings Date | Jul 31, 2017 - Aug 4, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 61.50 |
- GlobeNewswire•6 days ago
Amedisys Wins Five National Marketing Awards
BATON ROUGE, La., June 21, 2017-- Amedisys, Inc., one of the nation’ s leading home healthcare, hospice and personal care companies, was recently awarded five Aster Awards for its hospice marketing.. The ...
- Capital Cube•18 days ago
ETFs with exposure to Amedisys, Inc. : June 8, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amedisys, Inc. Here are 5 ETFs with the largest exposure to AMED-US. Comparing the performance and risk of Amedisys, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Zacks•21 days ago
Amedisys (AMED) Prospects Impressive Amid Tough Competition
On Jun 5, we issued an updated research report on leading molecular diagnostic company, Amedisys, Inc. (AMED).
